Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Inventory (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Change in Inventory for 13 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 250.59% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.6 million through Dec 2025, up 318.17% year-over-year, with the annual reading at $11.6 million for FY2025, 318.17% up from the prior year.
  • Change in Inventory for Q4 2025 was $2.0 million at Niagen Bioscience, down from $4.4 million in the prior quarter.
  • The five-year high for Change in Inventory was $4.4 million in Q3 2025, with the low at -$2.8 million in Q1 2023.
  • Average Change in Inventory over 5 years is $457200.0, with a median of $469000.0 recorded in 2021.
  • The sharpest move saw Change in Inventory soared 656.41% in 2023, then plummeted 1613.85% in 2024.
  • Over 5 years, Change in Inventory stood at $926000.0 in 2021, then crashed by 203.56% to -$959000.0 in 2022, then soared by 298.23% to $1.9 million in 2023, then tumbled by 171.12% to -$1.4 million in 2024, then surged by 250.59% to $2.0 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $2.0 million, $4.4 million, and $3.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.